Ziyang Xu

发表

Immunogenicity of a DNA vaccine candidate for COVID-19

J. Kim, D. Weiner, Jian Yan, 2020, Nature Communications.

In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity.

Daniel W. Kulp, D. Weiner, D. Montefiori, 2019, The Journal of clinical investigation.

Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

D. Weiner, H. Feldmann, Ami Patel, 2021, JCI insight.

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature communications.

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas

D. Weiner, P. Lieberman, K. Liaw, 2021, Molecular therapy oncolytics.

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity

Daniel W. Kulp, D. Weiner, W. Schief, 2020, Advanced science.

SARS-CoV-2 assays to detect functional antibody responses that block ACE2 1 recognition in vaccinated animals and infected patients 2

Daniel W. Kulp, D. Weiner, P. Tebas, 2020 .

Engineered DNA-encoded monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein confer single dose protection in a murine malaria challenge model

D. Weiner, Sophia M. Reeder, Ami Patel, 2022, Scientific reports.

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig

D. Weiner, Ami Patel, Ziyang Xu, 2018, EBioMedicine.

A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control

Daniel W. Kulp, D. Weiner, D. Kulp, 2020, Cancer Immunology Research.

Elicitation of immune responses against Nipah virus by an engineered synthetic DNA vaccine

D. Weiner, S. Kudchodkar, S. Ramos, 2022, Frontiers in Virology.

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo

D. Weiner, Ami Patel, Xizhou Zhu, 2020, Molecular therapy. Methods & clinical development.

SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

Daniel W. Kulp, D. Weiner, P. Tebas, 2020, Journal of Clinical Microbiology.

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

S. Mahalingam, A. Srinivasan, Ziyang Xu, 2021, Heliyon.

Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from Plasmodium Infection in a Murine Model

D. Weiner, Sophia M. Reeder, Ami Patel, 2021, Infection and immunity.

Immunogenicity of a DNA vaccine candidate for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020, Nature Communications.

Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer

Haiyuan Yu, Junnian Zheng, Ziyang Xu, 2021, Journal of Cancer.

Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy.

Jun-qi Wang, Ziyang Xu, L. Mao, 2021, Frontiers in bioscience.

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases

Daniel W. Kulp, D. Weiner, Ami Patel, 2020, Frontiers in Medical Technology.

Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2021, Cell Reports Medicine.

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

Daniel W. Kulp, D. Weiner, J. Pallesen, 2021, bioRxiv.

Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells

D. Weiner, M. Betts, C. Shikuma, 2021, PLoS pathogens.

Engineered DNA-encoded monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein confer single dose protection in a murine malaria challenge model

D. Weiner, Sophia M. Reeder, Ami Patel, 2022, Scientific Reports.

Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

Daniel W. Kulp, J. Kim, D. Weiner, 2020, bioRxiv.

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

A. Srinivasan, J. Maslow, M. Jeong, 2021, Translational Medicine Communications.

Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer

Daniel W. Kulp, D. Weiner, J. Pallesen, 2022, Nature Communications.

Protein engineering and particulate display of B-cell epitopes to facilitate development of novel vaccines.

Daniel W. Kulp, Ziyang Xu, 2019, Current opinion in immunology.

Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity.

Daniel W. Kulp, D. Weiner, Ziyang Xu, 2023, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

DNA-Encoded Glutamine Synthetase Enzyme as Ammonia-Lowering Therapeutic for Hyperammonemia.

D. Weiner, Ami Patel, Xizhou Zhu, 2020, Nucleic acid therapeutics.

mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic

D. Fisher, Ziyang Xu, 2023, Frontiers in Immunology.

Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo

Daniel W. Kulp, D. Weiner, S. Majumdar, 2023, Frontiers in Immunology.

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

D. Weiner, S. Kudchodkar, P. Tebas, 2020, PLoS neglected tropical diseases.

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

Daniel W. Kulp, D. Weiner, K. Ugen, 2021, ACS Pharmacology & Translational Science.

Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Responses Induced by DNA and Protein Vaccinations

Daniel W. Kulp, D. Weiner, Susanne N. Walker, 2020, iScience.

Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.

S. Kudchodkar, J. Maslow, M. Jeong, 2021, Methods in molecular biology.

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy

S. Kudchodkar, Ziyang Xu, N. Pardi, 2023, Antibodies.

An erythematous indurated plaque on the neck of a 12‐year‐old girl

Ziyang Xu, A. Rubin, Elizabeth M Margolskee, 2022, Pediatric dermatology.

Synthetic DNA Vaccines Adjuvanted with pIL-33 Drive Liver-Localized T Cells and Provide Protection from Plasmodium Challenge in a Mouse Model

D. Weiner, A. Aly, Sophia M. Reeder, 2020, Vaccines.

Regulation of CD8+ T memory and exhaustion by the mTOR signals

Haihui Yu, Bing Su, Ziyang Xu, 2023, Cellular & Molecular Immunology.

A healthy 16‐year‐old boy presenting with multifocal asymptomatic subcutaneous nodules

Ziyang Xu, A. Rubin, Elizabeth M Margolskee, 2022, Pediatric dermatology.

Covalent-fragment screening of BRD4 identifies a ligandable site orthogonal to the acetyl-lysine binding sites.

Michael D. Olp, Ziyang Xu, Stefan G. Kathman, 2020, ACS chemical biology.